Global Neratinib Market Growth 2025-2031

December 2025 | 76 pages | ID: GFF6C27734DEN
LP Information

Abstracts

The global Neratinib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Neratinib is a protein kinase inhibitor used to treat breast cancer that over expresses the HER2 receptor. It blocks the action of a protein called HER2, which can help tumors grow and spread. Neratinib is available in different tablet forms, such as 40mg/180 tablets, 40mg/150 tablets, and 40mg/90 tablets.

The global Neratinib market is expected to grow at a CAGR of 6.5% from 2022 to 20303. The growth in the market can be attributed to the increasing incidence of breast cancer, rising awareness about early diagnosis and treatment of breast cancer, and technological advancements in the field of oncology. Some of the key factors driving the market are the approval of Neratinib for other applications such as gastrointestinal stromal tumor and lung cancer, the launch of generic versions of Neratinib, and the expansion of the market in emerging regions such as Asia Pacific and Latin America.

LP Information, Inc. (LPI) ' newest research report, the “Neratinib Industry Forecast” looks at past sales and reviews total world Neratinib sales in 2024, providing a comprehensive analysis by region and market sector of projected Neratinib sales for 2025 through 2031. With Neratinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neratinib industry.

This Insight Report provides a comprehensive analysis of the global Neratinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neratinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neratinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neratinib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neratinib.

This report presents a comprehensive overview, market shares, and growth opportunities of Neratinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 40mg/180 Tablets
• 40mg/150 Tablets
• 40mg/90 Tablets

Segmentation by Application:

• Early Breast Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Puma Biotechnology
• Beacon Pharmaceuticals Limited

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neratinib market?

What factors are driving Neratinib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neratinib market opportunities vary by end market size?

How does Neratinib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neratinib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Neratinib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Neratinib by Country/Region, 2020, 2024 & 2031
2.2 Neratinib Segment by Type
  2.2.1 40mg/180 Tablets
  2.2.2 40mg/150 Tablets
  2.2.3 40mg/90 Tablets
2.3 Neratinib Sales by Type
  2.3.1 Global Neratinib Sales Market Share by Type (2020-2025)
  2.3.2 Global Neratinib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Neratinib Sale Price by Type (2020-2025)
2.4 Neratinib Segment by Application
  2.4.1 Early Breast Cancer
  2.4.2 Others
2.5 Neratinib Sales by Application
  2.5.1 Global Neratinib Sale Market Share by Application (2020-2025)
  2.5.2 Global Neratinib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Neratinib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Neratinib Breakdown Data by Company
  3.1.1 Global Neratinib Annual Sales by Company (2020-2025)
  3.1.2 Global Neratinib Sales Market Share by Company (2020-2025)
3.2 Global Neratinib Annual Revenue by Company (2020-2025)
  3.2.1 Global Neratinib Revenue by Company (2020-2025)
  3.2.2 Global Neratinib Revenue Market Share by Company (2020-2025)
3.3 Global Neratinib Sale Price by Company
3.4 Key Manufacturers Neratinib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Neratinib Product Location Distribution
  3.4.2 Players Neratinib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NERATINIB BY GEOGRAPHIC REGION

4.1 World Historic Neratinib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Neratinib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Neratinib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neratinib Market Size by Country/Region (2020-2025)
  4.2.1 Global Neratinib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Neratinib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neratinib Sales Growth
4.4 APAC Neratinib Sales Growth
4.5 Europe Neratinib Sales Growth
4.6 Middle East & Africa Neratinib Sales Growth

5 AMERICAS

5.1 Americas Neratinib Sales by Country
  5.1.1 Americas Neratinib Sales by Country (2020-2025)
  5.1.2 Americas Neratinib Revenue by Country (2020-2025)
5.2 Americas Neratinib Sales by Type (2020-2025)
5.3 Americas Neratinib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neratinib Sales by Region
  6.1.1 APAC Neratinib Sales by Region (2020-2025)
  6.1.2 APAC Neratinib Revenue by Region (2020-2025)
6.2 APAC Neratinib Sales by Type (2020-2025)
6.3 APAC Neratinib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Neratinib by Country
  7.1.1 Europe Neratinib Sales by Country (2020-2025)
  7.1.2 Europe Neratinib Revenue by Country (2020-2025)
7.2 Europe Neratinib Sales by Type (2020-2025)
7.3 Europe Neratinib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neratinib by Country
  8.1.1 Middle East & Africa Neratinib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Neratinib Revenue by Country (2020-2025)
8.2 Middle East & Africa Neratinib Sales by Type (2020-2025)
8.3 Middle East & Africa Neratinib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neratinib
10.3 Manufacturing Process Analysis of Neratinib
10.4 Industry Chain Structure of Neratinib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Neratinib Distributors
11.3 Neratinib Customer

12 WORLD FORECAST REVIEW FOR NERATINIB BY GEOGRAPHIC REGION

12.1 Global Neratinib Market Size Forecast by Region
  12.1.1 Global Neratinib Forecast by Region (2026-2031)
  12.1.2 Global Neratinib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neratinib Forecast by Type (2026-2031)
12.7 Global Neratinib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Puma Biotechnology
  13.1.1 Puma Biotechnology Company Information
  13.1.2 Puma Biotechnology Neratinib Product Portfolios and Specifications
  13.1.3 Puma Biotechnology Neratinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Puma Biotechnology Main Business Overview
  13.1.5 Puma Biotechnology Latest Developments
13.2 Beacon Pharmaceuticals Limited
  13.2.1 Beacon Pharmaceuticals Limited Company Information
  13.2.2 Beacon Pharmaceuticals Limited Neratinib Product Portfolios and Specifications
  13.2.3 Beacon Pharmaceuticals Limited Neratinib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Beacon Pharmaceuticals Limited Main Business Overview
  13.2.5 Beacon Pharmaceuticals Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neratinib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neratinib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 40mg/180Tablets
Table 4. Major Players of 40mg/150Tablets
Table 5. Major Players of 40mg/90Tablets
Table 6. Global Neratinib Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Neratinib Sales Market Share by Type (2020-2025)
Table 8. Global Neratinib Revenue by Type (2020-2025) & ($ million)
Table 9. Global Neratinib Revenue Market Share by Type (2020-2025)
Table 10. Global Neratinib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Neratinib Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Neratinib Sale Market Share by Application (2020-2025)
Table 13. Global Neratinib Revenue by Application (2020-2025) & ($ million)
Table 14. Global Neratinib Revenue Market Share by Application (2020-2025)
Table 15. Global Neratinib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Neratinib Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Neratinib Sales Market Share by Company (2020-2025)
Table 18. Global Neratinib Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Neratinib Revenue Market Share by Company (2020-2025)
Table 20. Global Neratinib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Neratinib Producing Area Distribution and Sales Area
Table 22. Players Neratinib Products Offered
Table 23. Neratinib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Neratinib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Neratinib Sales Market Share Geographic Region (2020-2025)
Table 28. Global Neratinib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Neratinib Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Neratinib Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Neratinib Sales Market Share by Country/Region (2020-2025)
Table 32. Global Neratinib Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Neratinib Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Neratinib Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Neratinib Sales Market Share by Country (2020-2025)
Table 36. Americas Neratinib Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Neratinib Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Neratinib Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Neratinib Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Neratinib Sales Market Share by Region (2020-2025)
Table 41. APAC Neratinib Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Neratinib Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Neratinib Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Neratinib Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Neratinib Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Neratinib Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Neratinib Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Neratinib Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Neratinib Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Neratinib Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Neratinib Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Neratinib
Table 53. Key Market Challenges & Risks of Neratinib
Table 54. Key Industry Trends of Neratinib
Table 55. Neratinib Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Neratinib Distributors List
Table 58. Neratinib Customer List
Table 59. Global Neratinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Neratinib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Neratinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Neratinib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Neratinib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Neratinib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Neratinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Neratinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Neratinib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Neratinib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Neratinib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Neratinib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Neratinib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Neratinib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Puma Biotechnology Basic Information, Neratinib Manufacturing Base, Sales Area and Its Competitors
Table 74. Puma Biotechnology Neratinib Product Portfolios and Specifications
Table 75. Puma Biotechnology Neratinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Puma Biotechnology Main Business
Table 77. Puma Biotechnology Latest Developments
Table 78. Beacon Pharmaceuticals Limited Basic Information, Neratinib Manufacturing Base, Sales Area and Its Competitors
Table 79. Beacon Pharmaceuticals Limited Neratinib Product Portfolios and Specifications
Table 80. Beacon Pharmaceuticals Limited Neratinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Beacon Pharmaceuticals Limited Main Business
Table 82. Beacon Pharmaceuticals Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Neratinib
Figure 2. Neratinib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neratinib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Neratinib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neratinib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neratinib Sales Market Share by Country/Region (2024)
Figure 10. Neratinib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 40mg/180Tablets
Figure 12. Product Picture of 40mg/150Tablets
Figure 13. Product Picture of 40mg/90Tablets
Figure 14. Global Neratinib Sales Market Share by Type in 2025
Figure 15. Global Neratinib Revenue Market Share by Type (2020-2025)
Figure 16. Neratinib Consumed in Early Breast Cancer
Figure 17. Global Neratinib Market: Early Breast Cancer (2020-2025) & (K Pcs)
Figure 18. Neratinib Consumed in Others
Figure 19. Global Neratinib Market: Others (2020-2025) & (K Pcs)
Figure 20. Global Neratinib Sale Market Share by Application (2024)
Figure 21. Global Neratinib Revenue Market Share by Application in 2025
Figure 22. Neratinib Sales by Company in 2025 (K Pcs)
Figure 23. Global Neratinib Sales Market Share by Company in 2025
Figure 24. Neratinib Revenue by Company in 2025 ($ millions)
Figure 25. Global Neratinib Revenue Market Share by Company in 2025
Figure 26. Global Neratinib Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Neratinib Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Neratinib Sales 2020-2025 (K Pcs)
Figure 29. Americas Neratinib Revenue 2020-2025 ($ millions)
Figure 30. APAC Neratinib Sales 2020-2025 (K Pcs)
Figure 31. APAC Neratinib Revenue 2020-2025 ($ millions)
Figure 32. Europe Neratinib Sales 2020-2025 (K Pcs)
Figure 33. Europe Neratinib Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Neratinib Sales 2020-2025 (K Pcs)
Figure 35. Middle East & Africa Neratinib Revenue 2020-2025 ($ millions)
Figure 36. Americas Neratinib Sales Market Share by Country in 2025
Figure 37. Americas Neratinib Revenue Market Share by Country (2020-2025)
Figure 38. Americas Neratinib Sales Market Share by Type (2020-2025)
Figure 39. Americas Neratinib Sales Market Share by Application (2020-2025)
Figure 40. United States Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Neratinib Sales Market Share by Region in 2025
Figure 45. APAC Neratinib Revenue Market Share by Region (2020-2025)
Figure 46. APAC Neratinib Sales Market Share by Type (2020-2025)
Figure 47. APAC Neratinib Sales Market Share by Application (2020-2025)
Figure 48. China Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 52. India Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Neratinib Sales Market Share by Country in 2025
Figure 56. Europe Neratinib Revenue Market Share by Country (2020-2025)
Figure 57. Europe Neratinib Sales Market Share by Type (2020-2025)
Figure 58. Europe Neratinib Sales Market Share by Application (2020-2025)
Figure 59. Germany Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 60. France Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Neratinib Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Neratinib Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Neratinib Sales Market Share by Application (2020-2025)
Figure 67. Egypt Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Neratinib Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Neratinib in 2025
Figure 73. Manufacturing Process Analysis of Neratinib
Figure 74. Industry Chain Structure of Neratinib
Figure 75. Channels of Distribution
Figure 76. Global Neratinib Sales Market Forecast by Region (2026-2031)
Figure 77. Global Neratinib Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Neratinib Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Neratinib Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Neratinib Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Neratinib Revenue Market Share Forecast by Application (2026-2031)